Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.

Publication ,  Journal Article
Fonarow, GC; Smith, EE; Saver, JL; Reeves, MJ; Bhatt, DL; Grau-Sepulveda, MV; Olson, DM; Hernandez, AF; Peterson, ED; Schwamm, LH
Published in: Circulation
February 22, 2011

BACKGROUND: The benefits of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke are time dependent, and guidelines recommend an arrival to treatment initiation (door-to-needle) time of ≤60 minutes. METHODS AND RESULTS: Data from acute ischemic stroke patients treated with tPA within 3 hours of symptom onset in 1082 hospitals participating in the Get With the Guidelines-Stroke Program from April 1, 2003, to September 30, 2009 were studied to determine frequency, patient and hospital characteristics, and temporal trends in patients treated with door-to-needle times ≤60 minutes. Among 25 504 ischemic stroke patients treated with tPA, door-to-needle time was ≤60 minutes in only 6790 (26.6%). Patient factors most strongly associated with door-to-needle time ≤60 minutes were younger age, male gender, white race, or no prior stroke. Hospital factors associated with ≤60 minute door-to-needle time included greater annual volumes of tPA-treated stroke patients. The proportion of patients with door-to-needle times ≤60 minutes varied widely by hospital (0% to 79.2%) and increased from 19.5% in 2003 to 29.1% in 2009 (P<0.0001). Despite similar stroke severity, in-hospital mortality was lower (adjusted odds ratio, 0.78; 95% confidence interval, 0.69 to 0.90; P<0.0003) and symptomatic intracranial hemorrhage was less frequent (4.7% versus 5.6%; P<0.0017) for patients with door-to-needle times ≤60 minutes compared with patients with door-to-needle times >60 minutes. CONCLUSIONS: Fewer than one-third of patients treated with intravenous tPA had door-to-needle times ≤60 minutes, with only modest improvement over the past 6.5 years. These findings support the need for a targeted initiative to improve the timeliness of reperfusion in acute ischemic stroke.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

February 22, 2011

Volume

123

Issue

7

Start / End Page

750 / 758

Location

United States

Related Subject Headings

  • United States
  • Tissue Plasminogen Activator
  • Time Factors
  • Stroke
  • Risk Factors
  • Practice Guidelines as Topic
  • Outcome Assessment, Health Care
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fonarow, G. C., Smith, E. E., Saver, J. L., Reeves, M. J., Bhatt, D. L., Grau-Sepulveda, M. V., … Schwamm, L. H. (2011). Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation, 123(7), 750–758. https://doi.org/10.1161/CIRCULATIONAHA.110.974675
Fonarow, Gregg C., Eric E. Smith, Jeffrey L. Saver, Mathew J. Reeves, Deepak L. Bhatt, Maria V. Grau-Sepulveda, DaiWai M. Olson, Adrian F. Hernandez, Eric D. Peterson, and Lee H. Schwamm. “Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.Circulation 123, no. 7 (February 22, 2011): 750–58. https://doi.org/10.1161/CIRCULATIONAHA.110.974675.
Fonarow, Gregg C., et al. “Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.Circulation, vol. 123, no. 7, Feb. 2011, pp. 750–58. Pubmed, doi:10.1161/CIRCULATIONAHA.110.974675.
Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, Olson DM, Hernandez AF, Peterson ED, Schwamm LH. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011 Feb 22;123(7):750–758.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

February 22, 2011

Volume

123

Issue

7

Start / End Page

750 / 758

Location

United States

Related Subject Headings

  • United States
  • Tissue Plasminogen Activator
  • Time Factors
  • Stroke
  • Risk Factors
  • Practice Guidelines as Topic
  • Outcome Assessment, Health Care
  • Middle Aged
  • Male
  • Humans